Sign in

Endometrial cancer

Current status: Curable in many cases

A cancer that starts in the lining of the womb, and usually happens after the menopause. The main sign is bleeding from the vagina after the menopause, between periods, or heavier than is normal for you. The most common treatment is surgery to remove the womb, sometimes with radiotherapy, chemotherapy or hormone medicine. Most cases are found early, before the cancer has spread, and these are usually cured.

Read more about endometrial cancer
Where research stands todayUpdated 18 Nov 2026

Trial-stage treatments and research studies you can joinOpen trials for referral

Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.

Filters

Country
City
Distance is calculated in your browser. Your city is not sent to us.
Type
Get notified of new trialsGermany, all cities, all phases
Your ageShows only trials that take people your age.
Phase
  1. Trial-stage treatmentPhase 2Taking people
    Tests patritumab deruxtecan in adults with several advanced solid tumors

    Tests patritumab deruxtecan in adults with advanced solid tumors, including melanoma and gastric cancer.

    Frankfurt, GermanyAge 18+
  2. Trial-stage treatmentPhase 3Taking people
    Tests sacituzumab tirumotecan with pembrolizumab in endometrial cancer

    Tests sacituzumab tirumotecan plus pembrolizumab in adults with advanced endometrial cancer.

    Aachen, GermanyAlso Berlin, Bonn, Detmold, Dresden, Hamburg, Jena, Kassel, Kiel, …Age 18+
  3. Trial-stage treatmentPhase 2Taking people
    Tests relacorilant with other treatments for gynecological cancers

    Tests relacorilant with other drugs in adults with ovarian or endometrial cancer.

    Aachen, GermanyAlso Berlin, KemptenAge 18+
  4. Trial-stage treatmentPhase 3Taking people
    Tests trastuzumab deruxtecan with immunotherapy for HER2-expressing endometrial cancer

    Tests a HER2-targeted drug with immunotherapy as first treatment in adults with advanced endometrial cancer.

    Berlin, GermanyAlso Chemnitz, Dresden, Essen, Hamburg, Kassel, Leipzig, MannheimAge 18+
  5. Trial-stage treatmentPhase 2Taking people
    Tests lighter follow-up treatment for early endometrial cancer with certain tumor gene profiles

    Tests reduced treatment after surgery in adults with early endometrial cancer.

    Schwäbisch Hall, GermanyAge 18+
  6. Trial-stage treatmentPhase 3Taking people
    Tests BNT323 or chemotherapy in people with recurring HER2-expressing uterine cancer

    Compares BNT323 with chemotherapy in adults with recurring uterine cancer previously treated with immunotherapy.

    Berlin, GermanyAlso Bonn, Dresden, Kassel, Leipzig, MunichAge 18+
  7. Trial-stage treatmentPhase 3Taking people
    Compares Rina-S with standard chemotherapy in endometrial cancer

    Tests Rina-S against standard chemotherapy in adults with recurrent endometrial cancer.

    Berlin, GermanyAlso Bonn, Hamburg, Lemgo, WiesbadenAge 18+
  8. Trial-stage treatmentPhase 1/2Taking people
    EIK1005 alone or with pembrolizumab for advanced solid tumors

    Tests EIK1005, alone and with pembrolizumab, in adults with advanced solid tumors.

    Berlin, GermanyAlso Deggendorf, HamburgAge 18+
  9. Trial-stage treatmentPhase 3Taking people
    Tests trastuzumab deruxtecan after surgery for HER2-expressing endometrial cancer

    Tests trastuzumab deruxtecan against standard chemotherapy in adults with HER2-expressing endometrial cancer.

    Detmold, GermanyAlso Dresden, Frankfurt Am Main, Hamburg, UlmAge 18+
  10. Trial-stage treatmentPhase 1/2Taking people
    Tests ifinatamab deruxtecan in several types of recurrent or spreading solid tumors

    Tests ifinatamab deruxtecan in adults with solid tumors that returned or spread.

    Berlin, GermanyAlso Heidelberg, Heilbronn, Leipzig, MainzAge 18+
  11. Trial-stage treatmentPhase 1/2Taking people
    Tests BNT329 safety in adults with advanced solid tumors expressing CA19-9

    Tests investigational drug BNT329 in adults with advanced solid cancers expressing CA19-9.

    Bochum, GermanyAlso München, UlmAge 18+
  12. Trial-stage treatmentPhase 3Taking people
    Testing radiotherapy with durvalumab after surgery for mismatch-repair deficient endometrial cancer

    Compares radiotherapy with durvalumab against radiotherapy with or without chemotherapy in endometrial cancer.

    Detmold, GermanyAlso Dresden, Hamburg, Leipzig, Munich, Ulm, Winnenden, WormsAge 18+
  13. Trial-stage treatmentPhase 1/2
    Tests AZD9574 alone and with other cancer drugs in advanced solid tumours

    Tests AZD9574 alone or with other drugs in adults with advanced, returned solid cancers.

    Bayern, GermanyAlso Berlin, Heidelberg, MainzAge 18 to 130
  14. Trial-stage treatmentPhase 1/2Taking people
    Tests AZD5335 alone or with other drugs in advanced solid tumors

    Tests the antibody-drug conjugate AZD5335 in adults with advanced solid tumors.

    Berlin, GermanyAlso Freiburg im Breisgau, Hanover, Leipzig, Mannheim, RegensburgAge 18 to 130
  15. Trial-stage treatmentPhase 1/2Taking people
    Tests rezatapopt in advanced solid tumors with a TP53 Y220C mutation

    Tests rezatapopt, alone or with pembrolizumab, in people with advanced TP53 Y220C tumors.

    Augsburg, GermanyAlso Essen, Frankfurt am Main, Hamburg, HeidelbergAge 12+
  16. Trial-stage treatmentPhase 2
    Tests datopotamab deruxtecan alone or combined with other drugs in advanced solid tumours

    Tests datopotamab deruxtecan, alone or combined, in adults with advanced solid tumours.

    Berlin, GermanyAlso Essen, Hanover, München, RegensburgAge 18 to 130
  17. Trial-stage treatmentPhase 1/2Taking people
    Tests elironrasib and daraxonrasib in advanced solid tumors with KRAS G12C mutation

    Tests two drugs, alone and together, in adults with advanced KRAS G12C-mutated cancers.

    Cologne, GermanyAlso Esslingen am Neckar, Moers, NurembergAge 18+
  18. Trial-stage treatmentPhase 2Taking people
    Tests ACR-368 alone or with low-dose gemcitabine for endometrial cancer

    Tests ACR-368, alone or with gemcitabine, in adults with endometrial cancer.

    Ulm, GermanyAge 18+
  19. Trial-stage treatmentPhase 1Taking people
    Tests BI 3820768 dose tolerability in advanced germ cell, endometrial, or ovarian cancer

    Tests increasing doses of BI 3820768 in adults with advanced, treatment-resistant cancers.

    Munich, GermanyAge 18+
  20. Trial-stage treatmentPhase 3Taking people
    Puxitatug samrotecan compared with chemotherapy in B7-H4-selected endometrial cancer

    Tests puxitatug samrotecan against chemotherapy in adults with advanced endometrial cancer that progressed.

    Amberg, GermanyAlso Detmold, Dresden, Freiburg im Breisgau, Hamburg, Heidelberg, Heilbronn, Kassel, Mainz, …Age 18+

Search the publications

The results open on the publications page in a new tab, so this page stays as it is.

Lists with this disease filtered

Where treatment stands

Most people are found at an early stage, when this cancer is usually cured; once it has spread far, it is rarely cured.

Approved: 7

Officially approved for this disease in the EU, the US, Switzerland or France.

Human testing stage: 27

Being tested in people. Many treatments at this stage are never approved.

Animal testing stage: 2

Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.

Lab research stage: 4

Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.

Support organisations

Patient organisations and helplines in Germany, for you and your family.

Endometrial cancer organisations in Germany

  • Krebsinformationsdienst (KID) des DKFZ

    Doctors answer cancer questions by phone or e-mail, free, every day from 8:00 to 20:00.

  • Deutsche Krebshilfe

    German non-profit cancer charity providing information on cancer types, early detection, prevention, therapy and self-help, and funding research and patient support.

  • Gynaekologische Krebserkrankungen Deutschland e.V.

    Association for women with gynaecological cancers, mainly ovarian cancer: information, support groups across Germany, help hotline, expert talks. ENGAGe member.

General support in Germany

  • TelefonSeelsorge Deutschland

    Free, anonymous 24/7 crisis and emotional support line across Germany (0800 111 0 111, 0800 111 0 222, 116 123), plus chat and e-mail.

  • gesund.bund.de

    The German Federal Ministry of Health's portal providing reliable, quality-assured health information on diseases, care and prevention.

  • Stiftung Unabhängige Patientenberatung Deutschland (UPD)

    Statutory independent foundation giving free advice to patients in Germany on health and health-law questions, including patient rights.

Frontlight Community

Endometrial cancer community in Germany

People living with endometrial cancer and those close to them share what they went through. Posts are not medical advice: ask your doctor about your own treatment.

Offer tissue or data

There are three ways to help research move faster.

Give tissue or bloodA biobank stores your sample so many research teams can use it.See open programmes
Share your health dataA patient registry collects your health data, without your name, for research.How to join
Take part as a healthy volunteerStudies also need people without the disease, for comparison. Family and friends can help.Volunteer

Approved treatments

7 medicines are approved for endometrial cancer in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.

Checked on 18 Nov 2026 in the official lists of the US (FDA), the EU (European Commission and EMA) and Switzerland (Swissmedic), which we read every day. The lists of Japan (PMDA, approvals since April 2004), France (ANSM, medicines approved in France only) and Taiwan (TFDA) were checked on 11 Nov 2026. For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. The French ratings are the opinions of the HAS Transparency Committee, from the French public medicines database (base de données publique des médicaments, newest opinion 10 Dec 2025). 4 uncertain matches are left out. Other countries' own approvals were not checked.

“Miracle cure” fact checker

Social media spreads misinformation. Paste here what you read, and we'll tell you whether there is scientific evidence behind it.

What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.

Before you pay for anything, ask three things

  1. Is there a published study in people?
  2. Can I have the full price in writing?
  3. What does my doctor say?

About endometrial cancer

Sources: NHS, NCI PDQ, MedlinePlus, NCI SEER

A cancer that starts in the lining of the womb, and usually happens after the menopause. The main sign is bleeding from the vagina after the menopause, between periods, or heavier than is normal for you. The most common treatment is surgery to remove the womb, sometimes with radiotherapy, chemotherapy or hormone medicine. Most cases are found early, before the cancer has spread, and these are usually cured.

What is it?

The womb (uterus) is where a baby grows during pregnancy. Endometrial cancer starts in the womb's lining, the endometrium. It is the most common kind of womb cancer. The cause is not known, but too much of the hormone oestrogen raises the risk.

It is most common in people who have been through the menopause, but anyone with a womb can get it. Being overweight, some kinds of hormone replacement therapy (HRT), diabetes, never having given birth, a late menopause and the breast cancer medicine tamoxifen raise the risk. It is more likely if close family have had womb, bowel or ovarian cancer, or with an inherited condition called Lynch syndrome. A healthy weight, regular exercise and a balanced diet can lower your chances.

The first signs

The most common sign is bleeding from the vagina that is not normal for you.

  • bleeding or spotting after the menopause;
  • heavy periods that are unusual for you, or bleeding between periods;
  • a change in the discharge from your vagina;
  • pain in the lower back or between the hips (pelvis), or pain during sex;
  • a lump or swelling in your tummy, or peeing or pooing more or less often than usual.

How doctors find out

Your family doctor asks about your symptoms and may examine your tummy and vagina; you can ask for a female doctor or nurse. If cancer is possible, they send you to a specialist. You may have a scan with a small device placed in the vagina, blood tests, a look inside the womb with a thin camera (hysteroscopy), and a biopsy, where cells are taken from the womb lining. The tests can feel uncomfortable but should not hurt.

Results usually take a few weeks. If it is cancer, more scans (CT, MRI or PET) and genetic tests show how far it has spread. A specialist nurse is your main contact during and after treatment.

Current treatment

Surgery to remove the womb is the main treatment, sometimes followed by radiotherapy or chemotherapy to lower the chance of the cancer coming back; hormone therapy, immunotherapy or targeted medicines are used when it has spread or come back.

Will it get worse?

How serious it is depends on how big the cancer is, whether it has spread, and your general health. Irregular bleeding usually makes people see a doctor early, so most cases are found before the cancer has spread; about two in three are still only in the womb when found. Cancer that has spread to other parts of the body is rarely cured.

Medicines: what helps, and what to watch for

Chemotherapy uses medicines to kill cancer cells. It can be given after surgery to lower the chance of the cancer coming back, together with radiotherapy, or to slow the cancer and ease symptoms if it has spread. Hormone therapy blocks the hormones some of these cancers need to grow; it can help when the cancer has spread or you are not well enough for surgery or radiotherapy. Immunotherapy, which helps your immune system find and kill cancer cells, and targeted medicines may be options for advanced cancer or cancer that comes back.

Good to know:

  • Common side effects of chemotherapy are tiredness, feeling sick, a sore mouth, hair loss for a while, and numbness or tingling in the hands or feet;
  • Radiotherapy can cause tiredness, diarrhoea (which should go within a few weeks of treatment ending), vaginal dryness or narrowing, and the menopause;
  • You do not need to wait for your next check-up to raise a side effect that worries you.

Radiotherapy, for some people

Radiotherapy uses high-energy rays to kill cancer cells. It can come from a machine outside the body or from a source placed inside, near the cancer. It may be given after surgery to lower the chance of the cancer coming back, and it can be the main treatment if you cannot have surgery. It can also ease symptoms.

Surgery, for some people

Surgery is the most common treatment, especially for early cancer. The surgeon removes the womb and the neck of the womb (cervix) in an operation called a hysterectomy. Sometimes the ovaries and fallopian tubes, nearby lymph nodes or the upper part of the vagina are removed too. If the cancer has spread or come back, surgery may also remove nearby parts, such as the ovaries and tubes, the bladder or the rectum. Recovery can take a long time. Your team will talk with you about what treatment means for having children.

Is there a cure?

Yes, often. When the cancer is found early and is only in the womb, treatment usually cures it. When it has spread far, it is rarely cured, and treatment aims to control it. Clinical trials are testing new treatments, and joining one may be an option for some people.

See the 437 trials you can join

Median survival

About 3 years with chemotherapy for stage III or IV

Measured in: Stage III or IV, with chemotherapy: the GOG-0209 trial (1,381 women)

The figures behind it

NCI PDQ (health professional): in the GOG-0209 trial (1,381 women), median overall survival was 37 months with carboplatin plus paclitaxel and 41 months with paclitaxel, doxorubicin and cisplatin; in advanced or recurrent cancer after earlier platinum treatment, it was 18.7 months with pembrolizumab plus lenvatinib vs 11.9 months with chemotherapy (KEYNOTE-775). Most cases are found early, and localized disease is usually cured.